Novo Nordisk sues competitor Eli Lilly over GLP-1 advertising

Novo Nordisk sues competitor Eli Lilly over GLP-1 advertising
FacebookXWhatsAppEmail

Novo Nordisk filed a lawsuit against rival Eli Lilly, accusing the latter of false advertising regarding weight-loss medications. Read more trending news Novo Nordisk said Eli Lilly’s claims that its medications work better than Novo’s are not true, Reuters reported. The lawsuit was filed in dist...